Addressing GLP-1 Related Skin Laxity with Sofwave: An FDA Cleared, Non-Invasive Solution for Face and Body The rapid rise in GLP-1 medication has fundamentally shifted the aesthetic treatment landscape. As more patients experience significant and sustained weight loss, practitioners are …
To access this post, you must purchase Aesthetics Journal Subscriptions – AJ Print & Digital Subscriber, Aesthetics Journal Subscriptions – AJ Digital Subscriber or Aesthetics Journal Subscriptions – AJ News Subscriber.
log in
log in
